Cell and Gene Therapy

Breaking

European Research Revolution: Day 1 Highlights RAPS Euro Convergence: Key Regulatory Updates - Day 1 Cellenkos Receives FDA Clearance for CK0802 Phase 2a Trial in Steroid-Refractory GVHD

NewsMay 5, 2026

Cryoport Q1 2026 Results: Revenue Jumps 26% Supporting Record 766 Clinical Trials and 21 Commercial Cell Gene Therapies

Cryoport reports 26% revenue growth in Q1 2026, supporting a record 766 global clinical trials and 21 commercially approved cell and gene therapies worldwide.

Dr. Priya Sharma

News by Topic

More News Topics

Press Releases

Analysis by Topic

More Analysis Topics

Whitepapers

Browse

By Region

Directory

By Region

For Suppliers

For Brands

Resources

Popular Topics

More Topics

Browse

About Us

Get in Touch

Quick Actions

Recent Searches

Popular Topics

Suggestions

Cryoport Q1 2026 Results: Revenue Jumps 26% Supporting Record 766 Clinical Trials and 21 Commercial Cell Gene Therapies